FDA investigates possible Vytorin link to cancer
Saturday, August 23, 2008 - 06:07
in Health & Medicine
(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.